Company Description

Reprogram Biosciences is a preclinical oncology biotechnology company that develops mRNA-based therapeutics to reprogram tumor cells to activate the immune system, focusing on treating solid tumors with high unmet need. Reprogram's CellRecodeX discovery platform uses biological foundation models to accelerate candidate identification and support pipeline expansion.